3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      EWSR1/FUS-CREB Fusions Define a Distinctive Malignant Epithelioid Neoplasm with Predilection for Mesothelial-Lined Cavities

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Gene fusions constitute pivotal driver mutations often encoding aberrant chimeric transcription factors. However, an increasing number of gene fusion events have been shown not to be histotype specific and shared among different tumor types, otherwise completely unrelated clinically or phenotypically. One such remarkable example of chromosomal translocation promiscuity is represented by fusions between EWSR1 or FUS with genes encoding for CREB-transcription factors family (ATF1, CREB1 and CREM), driving the pathogenesis of various tumor types spanning mesenchymal, neuroectodermal, and epithelial lineages. In this study we investigate a group of 13 previously unclassified malignant epithelioid neoplasms, frequently showing an epithelial immunophenotype and marked predilection for the peritoneal cavity, defined by EWSR1/FUS-CREB fusions. There were 7 females and 6 males, with a mean age of 36 (range 9–63). All except 3 cases occurred intra-abdominally, including one each involving the pleural cavity, upper and lower limb soft tissue. All tumors showed a predominantly epithelioid morphology associated with cystic or microcystic changes and variable lymphoid cuffing either intermixed or at the periphery. All except one case expressed EMA and/or CK, 5 were positive for WT1, while being negative for melanocytic and other mesothelioma markers. Nine cases were confirmed by various RNA sequencing platforms, while in the remaining 4 cases the gene rearrangements were detected by FISH. Eleven cases showed the presence of CREM-related fusions ( EWSR1-CREM, 7; FUS-CREM, 4), while the remaining 2 harbored EWSR1-ATF1 fusion. Clinically, 7 patients presented with and/or developed metastases, confirming a malignant biologic potential. Our findings expand the spectrum of tumors associated with CREB-related fusions, defining a novel malignant epithelioid neoplasm with an immunophenotype suggesting epithelial differentiation. This entity appears to display hybrid features between angiomatoid fibrous histiocytoma (cystic growth, lymphoid cuffing) and mesothelioma (peritoneal/pleural involvement, epithelioid phenotype, and cytokeratin and WT1 co-expression).

          Related collections

          Most cited references24

          • Record: found
          • Abstract: found
          • Article: not found

          Function and regulation of CREB family transcription factors in the nervous system.

          CREB and its close relatives are now widely accepted as prototypical stimulus-inducible transcription factors. In many cell types, these factors function as effector molecules that bring about cellular changes in response to discrete sets of instructions. In neurons, a wide range of extracellular stimuli are capable of activating CREB family members, and CREB-dependent gene expression has been implicated in complex and diverse processes ranging from development to plasticity to disease. In this review, we focus on the current level of understanding of where, when, and how CREB family members function in the nervous system.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Anchored multiplex PCR for targeted next-generation sequencing.

            We describe a rapid target enrichment method for next-generation sequencing, termed anchored multiplex PCR (AMP), that is compatible with low nucleic acid input from formalin-fixed paraffin-embedded (FFPE) specimens. AMP is effective in detecting gene rearrangements (without prior knowledge of the fusion partners), single nucleotide variants, insertions, deletions and copy number changes. Validation of a gene rearrangement panel using 319 FFPE samples showed 100% sensitivity (95% confidence limit: 96.5-100%) and 100% specificity (95% confidence limit: 99.3-100%) compared with reference assays. On the basis of our experience with performing AMP on 986 clinical FFPE samples, we show its potential as both a robust clinical assay and a powerful discovery tool, which we used to identify new therapeutically important gene fusions: ARHGEF2-NTRK1 and CHTOP-NTRK1 in glioblastoma, MSN-ROS1, TRIM4-BRAF, VAMP2-NRG1, TPM3-NTRK1 and RUFY2-RET in lung cancer, FGFR2-CREB5 in cholangiocarcinoma and PPL-NTRK1 in thyroid carcinoma. AMP is a scalable and efficient next-generation sequencing target enrichment method for research and clinical applications.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Transcriptional regulation by the phosphorylation-dependent factor CREB.

              The transcription factor CREB -- for 'cyclic AMP response element-binding protein' -- functions in glucose homeostasis, growth-factor-dependent cell survival, and has been implicated in learning and memory. CREB is phosphorylated in response to various signals, but how is specificity achieved in these signalling pathways?
                Bookmark

                Author and article information

                Journal
                8806605
                6644
                Mod Pathol
                Mod Pathol
                Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
                0893-3952
                1530-0285
                16 August 2020
                07 August 2020
                November 2020
                07 February 2021
                : 33
                : 11
                : 2233-2243
                Affiliations
                [1 ]Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, MD
                [2 ]Department of Oncology, The Johns Hopkins Medical Institutions, Baltimore, MD
                [3 ]Department of Pathology, Centre Hospitalier Universitaire de Quebec, Quebec City, Canada
                [4 ]Department of Pathology, Massachusetts General Hospital, Boston, MA
                [5 ]Department of Anatomical Pathology, Singapore General Hospital, Singapore
                [6 ]Department of Pathology and Medical Biology, University Medical Center, University of Groningen, Groningen, The Netherlands
                [7 ]Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY
                [8 ]Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany
                [9 ]Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
                Author notes
                Corresponding Author: Cristina R. Antonescu, MD, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, antonesc@ 123456mskcc.org
                Article
                NIHMS1615708
                10.1038/s41379-020-0646-5
                7584759
                32770123
                9ff23cb0-fe31-4f87-989e-dd2cdd1e9a93

                Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms

                History
                Categories
                Article

                Pathology
                ewsr1,crem,creb1,atf1,sarcoma,fusion,translocation
                Pathology
                ewsr1, crem, creb1, atf1, sarcoma, fusion, translocation

                Comments

                Comment on this article

                scite_

                Similar content25

                Cited by20

                Most referenced authors317